Abstract:Background: Although endometrial cancer is not ranked among the ten most common cancer types in Iran, it is the 12th most prevalent in women and the third most common cancer of the female genital tract after breast and ovarian cancer. The mortality rate of endometrial cancer in Iran is 0.6 in 100,000 persons. Several studies have evaluated the correlation of preoperative CA125 in endometrial cancer with several surgicopathologic and prognostic variables, disease recurrence, and the need for lymphadenectomy. Recent data have suggested adjuvant extrafascial hysterectomy after neoadjuvant therapy instead of the initial radical hysterectomy for locally advanced disease. Therefore, it would be helpful to use a preoperative assessment, including serum CA125 measurement to predict the extent of the disease and plan a less complicated therapy. Objectives: To evaluate the cut-off value of CA125 in parametrial and cervical stromal invasion of endometrioid endometrial cancer. Methods: A sample of 128 endometrial cancer cases, surgically staged from 2012 to 2018 in Imam Hossein Hospital were evaluated. According to the exclusion criteria, 82 cases were finally analyzed. A receiver operating characteristic (ROC) curve was used to determine the cut-off value of preoperative CA125 for parametrial and cervical stromal involvement. Results: A high preoperative CA125 level was significantly associated with advanced disease stage, cervical stromal invasion, pelvic lymph node metastases, and higher grade (P < 0.05); the test showed a marginally significant correlation for parametrial invasion, which may be due to sample size limitation (P = 0.058). However, the correlation between CA125 and myometrial/lymphovascular invasions were not statistically significant (P = 0.112 and P = 0.168, respectively). The optimal cut-off value for preoperative CA125 was 45.5 u/mL in parametrial invasion (100% sensitivity, 89% specificity, 33.3% positive predictive value, and 100% negative predictive value), and 41.9 u/mL for cervical stromal invasion (87.5% sensitivity, 87.8% specificity, 43.75% positive predictive value, and 98.48% negative predictive value). Conclusions: Primary radical surgery may not be the first treatment approach in cervical/parametrial involvement. Neoadjuvant (chemo)radiotherapy and adjuvant extrafascial hysterectomy could be an alternative approach with fewer complications. Using preoperative CA125 along with physical examination and imaging modalities would be helpful in this regard. More investigations are needed to assess an agreed cut-off value for preoperative CA125 and endometrial cancer extension. CA-125 Antigen Preoperative Care ROC Curve Carcinoma Endometrioid Hysterectomy

Preoperative screening endometrial cytology discovered incidental gynaecological malignancy in two patients undergoing risk-reducing salpingo-oophorectomy

Ovarian malignancies incidentally diagnosed during cesarean section: analysis of 13 cases.

Ovarian surveillance including endometrial cytology for patients with hereditary breast and ovarian cancer before risk‐reducing salpingo‐oophorectomy: A retrospective analysis

Early Cervical Cancer Recurred with Uterine Fundus Metastasis after Laparoscopic Fertility-Sparing Surgery: A Case Report

Risk-reducing Salpingo-Oophorectomy among Chinese Women at Increased Risk of Breast and Ovarian Cancer.

Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma

Early oncological outcomes and accuracy of risk stratification and tailoring surgical staging based on preoperative histology, Ca125 and MRI in endometrial cancer: a prospective cohort study

The Role of Endometrial Sampling before Hysterectomy in Premenopausal Women with Abnormal Uterine Bleeding

Risk-reducing salpingectomy with delayed oophorectomy to prevent ovarian cancer in women with an increased inherited risk: insights into an alternative strategy

Preoperative serum CA125: a useful marker for surgical management of endometrial cancer

Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study

Hysteroscopy combined dilatation and curettage, serum CA125 and CA19-9 play an important role in preserving fertility or endocrine function for early-stage endometrial cancer patients

Peritoneal cancer arising after total abdominal hysterectomy and bilateral salpingo-oophorectomy for cervical cancer in a patient with right breast cancer and germline mutation of BRCA1 gene: a case report and literature review

Successful Surveillance Using Endometrial Cytology in a Woman With Lynch Syndrome

Are preoperative serum cancer antigen 125 levels a prognostic factor for outcome in epithelial ovarian cancer? A systematic review

Preoperative Evaluation Of Serum Ca-125 Levels Maybe A More Significantly Prognostic Factor In Low To Intermediate-Risk Endometrial Carcinoma: A Multi-Institutional Study

The Prognostic Value of Preoperative Serum CA125 in Endometrioid Endometrial Cancer with Cervical Stromal and Parametrial Invasion

Study on the psychosocial aspects of risk-reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutation carriers in Japan: a preliminary report

Screening and prevention of ovarian cancer

Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study

Genetic Disorders Requiring Risk-Reducing Surgical Management in Our Gynecological Oncology Practice